Fujifilm to examine the effectiveness of AI technology deployed in medical services
To verify the effectiveness of AI technology which assists diagnostic imaging in India, Fujifilm Corporation has launched a project as a new initiative in the company’s health screening service business for the emerging countries. This
To verify the effectiveness of AI technology which assists diagnostic imaging in India, Fujifilm Corporation has launched a project as a new initiative in the company’s health screening service business for the emerging countries. This project will be conducted at a health screening centre that Fujifilm opened in Bengaluru (India) in February this year known as the NURA.
This project has been recognized as the “Asia Digital Transformation Promotion Projects” by the Japanese Ministry of Economy, Trade and Industry as it has the potential to solve prevalent social issues in Asian countries.
NURA, is the first health screening centre that focuses on cancer screening in Bengaluru. It offers Fujifilm’s medical devices which provide high-definition diagnostic images. The medical IT systems at these centres are based on AI technology to support doctors to carry out screening and tests for diagnosing cancer and lifestyle diseases.
The project that is launched to test effectiveness of AI will examine chest CT scan data of 2,000 NURA visitors to verify whether medical diagnosis using AI technology imaging can effectively prevent doctors from overlooking legions or improve the speed of interpreting images. Doctors’ interpretation of CT scan data examined with the support of the AI technology will be compared against different doctors’ interpretations made without the support of the AI technology, claims Fujifilm.
At the same time, Fujifilm will also try to examine whether it is possible to deploy health-screening services effectively with limited medical resources in emerging countries or not in order to expand the use of AI technology to other medical services.